Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective

31 Jan 2020

Abstract excerpt

INTRODUCTION: Aberrant pharmacogenetic variants occur in a high proportion of people and might be relevant for the prescription of over 26 drugs in primary care. Early identification of patients who metabolize these drugs more rapidly or slowly than average could predict therapeutic effectivity and safety. Yet implementation of pharmacogenetics is progressing slowly. A high public health impact can potentially be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Ethics in Clinical Research
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32076434
DOI: 10.3389/fgene.2020.00010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder PerspectivePMID 32076434Read ↗

Moving Pharmacogenetics Into Practice: It’s All About the Evidence!Semantic proximity Read ↗

Are Pharmacists from the Province of Quebec Ready to Integrate Pharmacogenetics into their PracticeSemantic proximity Read ↗

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.Semantic proximity Read ↗

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining ChallengesSemantic proximity Read ↗

A qualitative approach to assess the opinion of physicians about the challenges and future prospects of pharmacogenomic testing implementation in clinical practice.Semantic proximity Read ↗

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare SettingSemantic proximity Read ↗

Precision medicine from a citizen perspective: a survey of public attitudes towards pharmacogenomics in FlandersSemantic proximity Read ↗

Practical barriers and facilitators experienced by patients, pharmacists and physicians to the implementation of pharmacogenomic screening in Dutch outpatient hospital care – an explorative pilot studySemantic proximity Read ↗

Lessons from clinical implementation of a preemptive pharmacogenetic panel as part of a testing pilot program with an employer-sponsored medical planSemantic proximity Read ↗

Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The NetherlandsSemantic proximity Read ↗

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World ImplementationSemantic proximity Read ↗

Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical SettingsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.